ClinicalTrials.gov Identifier: Pending

Title: Teen OCD TMS study

As many as 50% of children and adolescents with Obsessive Compulsive Disorder (OCD) experience continuing significant and impairing symptoms even after receiving medication and cognitive-behavioral therapy.

The goal of this pilot study is to explore if adding Transcranial Magnetic Stimulation (TMS) to ongoing treatments can lead to further improvement and even remission of OCD in teens who have experienced limited or no response to usual treatment with medication and/or cognitive-behavioral therapy (CBT).

TMS is FDA-approved for treatment resistant OCD in adults, and is safe in children and teens, but TMS has not been carefully studied in adolescent OCD.

If eligible, all adolescents in the study will receive a 3-week intensive TMS treatment under close monitoring as well as a MRI of the brain before and after TMS.

This project’s goal is to determine whether treatment with TMS administered to one of two assigned stimulation sites proves to be acceptable and shows some evidence of benefits in adolescents with OCD. The study is led by Drs. James McCracken and A Moses Lee.

 Please fill out this form if you Or Your Teen are interested in participatinG In this Study